France Stomach Cancer Treatment Market Size & Outlook

The stomach cancer treatment market in France is expected to reach a projected revenue of US$ 187.2 million by 2028. A compound annual growth rate of 11.4% is expected of France stomach cancer treatment market from 2021 to 2028.
Revenue, 2020 (US$M)
$79.1
Forecast, 2028 (US$M)
$285.7
CAGR, 2021 - 2028
17.4%
Report Coverage
France

France stomach cancer treatment market highlights

  • The France stomach cancer treatment market generated a revenue of USD 79.1 million in 2020 and is expected to reach USD 285.7 million by 2028.
  • The France market is expected to grow at a CAGR of 17.4% from 2021 to 2028.
  • In terms of segment, targeted therapy was the largest revenue generating treatment type in 2020.
  • Targeted Therapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.


Stomach cancer treatment market data book summary

Market revenue in 2020USD 79.1 million
Market revenue in 2028USD 285.7 million
Growth rate17.4% (CAGR from 2020 to 2028)
Largest segmentTargeted therapy
Fastest growing segmentTargeted Therapy
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationStandard Chemotherapy, Targeted Therapy
Key market players worldwideNovartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis


Other key industry trends

  • In terms of revenue, France accounted for 2.3% of the global stomach cancer treatment market in 2020.
  • Country-wise, Japan is expected to lead the global market in terms of revenue in 2028.
  • In Europe, Germany stomach cancer treatment market is projected to lead the regional market in terms of revenue in 2028.
  • France is the fastest growing regional market in Europe and is projected to reach USD 285.7 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Stomach Cancer Treatment Market Companies

Name Profile # Employees HQ Website

France stomach cancer treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.


Targeted therapy was the largest segment with a revenue share of 50.19% in 2020. Horizon Databook has segmented the France stomach cancer treatment market based on standard chemotherapy, targeted therapy covering the revenue growth of each sub-segment from 2018 to 2028.


Reasons to subscribe to France stomach cancer treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France stomach cancer treatment market databook

  • Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France stomach cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into France stomach cancer treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France stomach cancer treatment market size, by treatment type, 2018-2028 (US$M)

France Stomach Cancer Treatment Market Outlook Share, 2020 & 2028 (US$M)

France stomach cancer treatment market size, by treatment type, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more